Geschichte und Zukunft der Medizinischen Forschung am Albert Schweitzer Spital in Lambaréné, Gabun

Michael Ramharter1,2, Ayôla Akim Adegnika3,2, Sélidji Todagbé Agnandji2,3, Pierre Blaise Matsiegui3,2, Martin P. Grobusch2,4, Stefan Winkler1, Wolfgang Graninger1, Sanjeev Krishna5, Maria Yazdanbakhsh6, Benjamin Mordmüller3,2, Bertrand Lell3,2, Michel A. Missinou3,2, Elie Mavoungou3,2, Saadou Issifou3,2, Peter G. Kremsner3,2
1Department of Medicine I, Division of Infectious Diseases, Medical University of Vienna, Austria
2Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon
3Institute for Tropical Medicine, Department for Parasitology, University of Tübingen, Germany
4NHLS and CMID, University of the Witwatersrand, Johannesburg, South Africa
5Department of Cellular and Molecular Medicine, St. George’s Hospital Medical School, London, UK
6Department of Parasitology, Leiden University Medical Center, Leiden, Netherlands

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kremsner PG, Krishna S (2004) Antimalarial combinations. Lancet 364 (9430): 285–294

Lell B, Kremsner PG (2002) Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother 46 (8): 2315–2320

Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W (1994) Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis 69 (2): 467–470

Kremsner PG, Winkler S, Brandts C, Graninger W, Bienzle U (1993) Curing of chloroquine-resistant malaria with clindamycin. Am J Trop Med Hyg 49 (5): 650–654

Lell B, Luckner D, Ndjave M, Scott T, Kremsner PG (1998) Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 351 (9104): 709–713

Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG (1996) Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347 (9014): 1511–1514

Faucher JF, Binder R, Missinou MA, Matsiegui PB, Gruss H, Neubauer R, et al (2002) Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis 35 (10): 1147–1154

Lell B, Faucher JF, Missinou MA, Borrmann S, Dangelmaier O, Horton J, et al (2000) Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet 355 (9220): 2041–2045

Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, et al (2002) Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359 (9315): 1365–1372

Alloueche A, Bailey W, Barton S, Bwika J, Chimpeni P, Falade CO, et al (2004) Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. Lancet 363 (9424): 1843–1848

Borrmann S, Lundgren I, Oyakhirome S, Impouma B, Matsiegui PB, Adegnika AA, et al (2006) Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria. Antimicrob Agents Chemother 50 (8): 2713–2718

Borrmann S, Adegnika AA, Moussavou F, Oyakhirome S, Esser G, Matsiegui PB, et al (2005) Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother 49 (9): 3749–3754

Missinou MA, Borrmann S, Schindler A, Issifou S, Adegnika AA, Matsiegui PB, et al (2002) Fosmidomycin for malaria. Lancet 360 (9349): 1941–1942

Oyakhirome S, Issifou S, Pongratz P, Barondi F, Ramharter M, Kun JF, et al (2007) Fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria: a randomised controlled trial. Antimicrob Agents Chemother 51 (5): 1869–1871

Ramharter M, Oyakhirome S, Klouwenberg PK, Adegnika AA, Agnandji ST, Missinou MA, et al (2005) Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis 40 (12): 1777–1784

Adegnika AA, Breitling LP, Agnandji ST, Chai SK, Schutte D, Oyakhirome S, et al (2005) Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambarene, Gabon. Am J Trop Med Hyg 73 (2): 263–266

Ramharter M, Grobusch MP, Kiessling G, Adegnika AA, Moller U, Agnandji ST, et al (2005) Clinical and parasitological characteristics of puerperal malaria. J Infect Dis 191 (6): 1005–1009

Ramharter M, Chai SK, Adegnika AA, Klopfer A, Langin M, Agnandji ST, et al (2004) Shared breastfeeding in central Africa. AIDS 18 (13): 1847–1849

Kun JF, Mordmuller B, Lell B, Lehman LG, Luckner D, Kremsner PG (1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351 (9098): 265–266

Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, et al (2001) Nitric oxide synthase 2 (Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 184 (3): 330–336

Uhlemann AC, Szlezak NA, Vonthein R, Tomiuk J, Emmer SA, Lell B, et al (2004) DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria. J Infect Dis 189 (12): 2227–2234

Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, et al (1999) Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 179 (4): 980–988

Greve B, Lehman LG, Lell B, Luckner D, Schmidt-Ott R, Kremsner PG (1999) High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J Infect Dis 179 (6): 1584–1586

Greve B, Kremsner PG, Lell B, Luckner D, Schmid D (2000) Malarial anaemia in African children associated with high oxygen-radical production. Lancet 355 (9197): 40–41

Bouyou-Akotet MK, Adegnika AA, Agnandji ST, Ngou-Milama E, Kombila M, Kremsner PG, et al (2005) Cortisol and susceptibility to malaria during pregnancy. Microbes Infect 7 (11–12): 1217–1223

Mavoungou E, Luty AJ, Kremsner PG (2003) Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum infected human red blood cells in vitro. Eur Cytokine Netw 14 (3): 134–142

Mavoungou E, Held J, Mewono L, Kremsner PG (2007) A Duffy binding like domain (DBL-1) is involved in the NKp30 mediated recognition of Plasmodium falciparum parasitized erythrocytes by natural killer cells. J Infect Dis 195 (10): 1521–1531

Bouyou-Akotet MK, Issifou S, Meye JF, Kombila M, Ngou-Milama E, Luty AJ, et al (2004) Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies. Clin Infect Dis 38 (3): 342–347

Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M (1996) Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 26 (6): 1365–1370

van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, et al (2000) Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356 (9243): 1723–1727

Winkler S, Willheim M, Baier K, Aichelburg A, Kremsner PG, Graninger W (1999) Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. Am J Trop Med Hyg 60 (4): 680–686

Lell B, Borrmann S, Yazdanbakhsh M, Kremsner PG (2001) Atopy and malaria. Wien Klin Wochenschr 113 (23–24): 927–929

Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296 (5567): 490–494